Stock listing

NGM:PHAL Pharmalundensis AB Aktie

Follow Pharmalundensis AB into a list and get an email when it puts out news.

Pharmalundensis AB logo
Ticker
NGM:PHAL
Asset type
Stock
Exchange
NGM
Currency
SEK

What changed lately

Latest news

PHAL: Net loss widened to -1.56 million SEK; delisting and international financing initiatives underway

May 28, 2026

PHAL: Net loss deepened in 2025 as focus shifts to international funding and clinical trial execution

Feb 5, 2026

PHAL: Net loss increased, but strong market interest in Minievaporator offers future upside

Nov 20, 2025

PHAL: Losses increased as net sales stayed at zero; new capital extends operations but debt remains

Aug 21, 2025

PHAL: Net loss persists, but R&D and cleantech advances drive optimism amid tight liquidity

May 15, 2025

PHAL: Net loss narrowed, Phal-501 advanced, and major rights issue to fund clinical trials in 2025

Feb 12, 2025

PHAL: Phal-501 shows promise for heavy metal detox; funding secured, but more needed by 2025

Nov 21, 2024

PHAL: Phal-501 clinical prep and rights issue mark key steps as losses narrow and CleanTech gains traction

Aug 15, 2024

All Pharmalundensis AB news

Pharmalundensis AB on 6ix

News releases
3 in the last 12 months · 8 in all · newest May 28, 2026 · oldest 2024

Log in to ask 6ix AI your own questions about Pharmalundensis AB.